Medical News

RSS

Machine learning helps researchers to distinguish a rare subtype of kidney cancer

Putting together research for publication can be a challenging and time-consuming process, heightened even further because of the current COVID-19 situation, during which non-essential labs have been hibernated and many researchers are now working separately and remotely, instead of collaborating within the same space.

21 Apr 2020

The inside story of how the Bay Area got ahead of the COVID-19 crisis

Sunday was supposed to be a rare day off for Dr. Tomás Aragón after weeks of working around-the-clock.

21 Apr 2020

Drinking water disparities are driven by segregation and local funding gaps

As droughts become more frequent and intense, the fragmentation of water service in the U.S. among tens of thousands of community systems, most of which are small and rely on local funding, leaves many households vulnerable to water contamination or loss of service, a new Duke University analysis finds.

21 Apr 2020

San Francisco quick to fight COVID-19, slow to help homeless

San Francisco Mayor London Breed has won nationwide praise for taking drastic early measures against COVID-19 that seem to have spared San Francisco the catastrophic fate of New York and other cities.

21 Apr 2020

Study shows why MDS cells have a competitive advantage that supports disease progression

A powerful clue has emerged in a long-running mystery about how the cells of myelodysplastic syndrome (MDS) manage to outcompete normal blood cells to cause a disease state that often leads to leukemia, according to a study published online April 20, 2020, in Nature Immunology.

21 Apr 2020

A switch to Medicaid managed care worries some Illinois foster families

Rebecca and Bruce Austin in central Illinois have six kids — ranging in age from 4 to 22.

21 Apr 2020

How Hong Kong reduced COVID-19 transmission

Amid the coronavirus disease (COVID-19) pandemic, many countries across the globe have imposed lockdowns in an attempt to reduce the spread of the virus. Still, some countries have not opted for lockdowns, and community quarantines, and still are doing well. Hong Kong, for one, appears to have averted a major COVID-19 outbreak despite not imposing lockdown.

21 Apr 2020

Australia may beat the novel coronavirus, modeling shows

Many countries are now in lockdown in an attempt to contain the spread of the novel coronavirus, now called the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus has sickened 2.47 million people worldwide, triggering many preventive measures. Now, it appears that preventive measures taken in Australia are containing the virus, according to a new modeling.

21 Apr 2020

Scientists use genomics and bioinformatics to analyze blueprint of novel coronavirus

Australian researchers from the Commonwealth Scientific and Industrial Research Organization (CSIRO) have found a new way to decode the genome of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 disease. This approach could help in drug and vaccine development. Their work titled, "Supporting pandemic response using genomics and bioinformatics: a case study on the emergent SARS-CoV-2 outbreak," is published in the latest issue of the journal Transboundary and Emerging Diseases.

21 Apr 2020

COVID-19 and immunodeficiency

COVID-19 disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a highly infectious disease. As of today, over 170,000 people worldwide have succumbed to the infection. Reports have shown that some comorbidities and illnesses raise the risk of getting infected and also influence the severity of the disease. Having a compromised immune system can also drastically raise the risk of getting COVID-19.

21 Apr 2020

Does high COVID-19 viral load mean more risk of infection?

The risk of getting infected with COVID-19 disease is higher among healthcare workers who are in close contact with infected patients

21 Apr 2020

Role of ACE/ARB inhibitors in the treatment of COVID-19

A new opinion piece published in the journal Circulation Research in April 2020 defends the use of antihypertensive drugs called ACE inhibitors and ARBs in patients with pandemic viral pneumonia called COVID-19.

20 Apr 2020

Research could help stabilize and improve brain-computer interfaces

Researchers from Carnegie Mellon University and the University of Pittsburgh have published research in Nature Biomedical Engineering that will drastically improve brain-computer interfaces and their ability to remain stabilized during use, greatly reducing or potentially eliminating the need to recalibrate these devices during or between experiments.

20 Apr 2020

University of Utah invests $1.3 million in multidisciplinary COVID-19 research projects

As the COVID-19 pandemic continues to spread across the globe, University of Utah scientists are at the forefront of efforts to learn more about how to lasso the virus that causes it and understand its potential long-term social, economic, and psychological effects.

20 Apr 2020

Discovery could open door to the development of new anti-cancer drugs

A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.

20 Apr 2020

CSIRO researchers unveil new approach to understand evolving SARS-CoV-2 virus strains

Researchers from CSIRO, Australia's national science agency, have unveiled a new approach to analyzing the genetic codes - or the blueprint - of the SARS-CoV-2 virus that causes COVID-19.

20 Apr 2020

McKelvey engineers receive federal funding for rapid COVID-19 test

Engineers at the McKelvey School of Engineering at Washington University in St. Louis have received federal funding for a rapid COVID-19 test using a newly developed technology.

20 Apr 2020

ACE2 receptor expression by SARS-CoV-2 across different animal species

A new report published on the preprint server bioRxiv in April 2020 reports that several species of animals can be infected with relative ease by the SARS-CoV-2 virus that is the causative agent of the currently raging COVID-19 pandemic. This casts much light on the possible natural hosts and routes of transmission of this virus.

20 Apr 2020

ATS publishes first official clinical practice guidelines for sarcoidosis

New guidance is available for physicians who must go through a number of steps to provide a probable diagnosis of sarcoidosis - an inflammatory disease that affects the lungs, lymph glands, and other organs.

20 Apr 2020

Mutations in novel coronavirus make it more dangerous

A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.

20 Apr 2020